Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Synthetic Biologics Inc (NYSE MKT LLC:SYN)

2.21
Delayed Data
As of Sep 03
 -0.08 / -3.49%
Today’s Change
1.34
Today|||52-Week Range
4.32
+51.37%
Year-to-Date
No recent news for Synthetic Biologics Inc.

Today’s Trading

Previous close2.29
Today’s open2.30
Day’s range2.15 - 2.32
Volume917,877
Average volume (3 months)2,026,232
Market cap$202.7M
Dividend yield--
Data as of 4:00pm ET, 09/03/2015

Growth & Valuation

Earnings growth (last year)-18.52%
Earnings growth (this year)-83.33%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book17.38

Competitors

 Today’s
change
Today’s
% change
OCATOcata Therapeutics I...-0.31-6.39%
ACRXAcelRx Pharmaceutica...-0.36-8.04%
MRNSMarinus Pharmaceutic...-0.11-0.80%
--China Health Group I...-0.03-13.06%
Data as of 3:59pm ET, 09/03/2015

Financials

Next reporting dateNovember 16, 2015
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$0.00
Annual profit (last year)-$19.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jeffrey Lucero Riley
Chief Financial Officer, Secretary &
Treasurer
Steven A. Shallcross
Corporate headquarters
Rockville, Maryland

Forecasts

Partner Offers